| 2025-10-28 |
MAEU259627715 |
GLENMARK PHARMACEUTICALS INC |
8801.65 kg |
551342.0
|
PACKAGES CARTONS PHARMACEUTICALS AS UNDER MARLISSA TAB . . MG NDC CO DE FDA PRODUCT CODE NO. G D A H. T. S NO. . . ANDA NO. THERAPEUTICE USE ORAL CONTRACEPTIVE OMEPRAZOLE DR CAP MG NDC CODE FDA PRODUCT CODE NO. KCF HTS NO. . . ANDA NO. THERAPEUTICE USE T |
| 2025-10-28 |
MAEU259627709 |
GLENMARK PHARMACEUTICALS INC |
10440.96 kg |
551342.0
|
PACKAGES CARTONS PHARMACEUTICALS AS UNDER ATOMOXETINE CAP MG NDC CODE FDA PRODUCT CODE NO. UCA H. T. S NO. . . . ANDA NO. TREATMENT OF ATTENTION DEFICITHYPERACIVITY DISORDER (ADHD TOPIRAMATE TAB MG NDC CODE FDA PRODUCT CODE NO. M C A H. T. S NO. . . . AND |
| 2025-10-21 |
EXDO62C0271432 |
AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH PACKAGING |
6951.0 kg |
520300.0
|
ONDANSETRON ODT HTS: |
| 2025-10-21 |
MAEU259468301 |
GLENMARK PHARMACEUTICALS INC |
7782.87 kg |
551342.0
|
PACKAGES CARTONS PHARMACEUTICALS AS U NDER NORETHINDRONE TAB . MG NDC CODE FDA PRODUCT CODE NO. J C A H. T. S NO. . . . ANDA NO. THERAPEU TICE USE PREVENTION OF PREGNANCY. NORETH ACE EE TAB MG MCG NDC CODE FDA PRO DUCT CODE NO. J D A H. T. S NO. . . . AND |
| 2025-10-21 |
MAEU259555784 |
GLENMARK PHARMACEUTICALS INC |
8896.46 kg |
847490.0
|
PART OF FCL PACKAGES CARTONS PHARMAC EUTICALS AS UNDER CLINDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . . ANDA NO. THERAPEUTICE USE TREATMENT OF NUMEROUS INFECTIONS INCLUDING BUT NOT LIMITED TO SEPTICEMIAINTRAABDOMINAL INFECTIONS L |
| 2025-10-21 |
MAEU259468305 |
GLENMARK PHARMACEUTICALS INC |
2253.48 kg |
551342.0
|
PART OF FCL PACKAGES CARTONS PHARMAC EUTICALS AS UNDER APREPITANT CAP MG UD ND C CODE FDA PRODUCT CODE NO. T C E H. T. S NO. . . . ANDA NO. THERAPEUTICE USEAPREPITANT IS USED WITH OTH ER MEDICATIONS TO HELP PREVENT NAUSEA AND VOMITING CAUSED BY CANCER DRU |
| 2025-10-20 |
MAEU258996624 |
HIKMA PHARMACEUTICALAS USA INC |
1069.59 kg |
551342.0
|
PACKAGES CARTONS PHARMACEUTICALS AS UNDE R RYALTRIS MD US NDC CODE FDA PRODUCT CODE NO. G C A H. T. S NO. . . ANDA NO. THERAPEUTICE USE IN DICATEDFOR THE TREATMENT OF SYMPTOMS ASSOCIATED WITH ALLERGIC RHINITIS AND RHINOCONJUNCTIVITIS COMMERCIAL CUSTOM INV |
| 2025-10-14 |
MAEU259264985 |
GLENMARK PHARMACEUTICALS INC |
5753.92 kg |
290719.0
|
PART OF FCL PACKAGES CARTONS PHARMAC EUTICALS AS UNDER CARVEDILOL TAB . MG NDC CODE FDA PRODUCT CODE NO O C A HTS NO. . . ANDA NO. THER APEUTICE USEBETA ADRENOACEPTOR ANTAGONIST CL INDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO . . . |
| 2025-10-14 |
MAEU258745479 |
GLENMARK PHARMACEUTICALS INC |
4596.78 kg |
551342.0
|
PART OF FCL PACKAGES CARTONS PHARMACE UTICALS AS UNDER ROSUVASTATIN TAB MG ND C CODE FDA PRODUCT CODE NO. J C A H. T. S NO. . . . ANDA NO. THERAPEUTICE USE TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS AND TO PREVENT CARDIO VASCULAR DISEASE NITROGLYCER |
| 2025-10-14 |
MAEU258745438 |
GLENMARK PHARMACEUTICALS INC |
6693.78 kg |
290719.0
|
PART OF FCL PACKAGES CARTONS PHARMAC EUTICALS AS UNDER SIROLIMUS TAB MG NDC CODE FDA PRODUCT CODE NO. T C A H. T. S NO. . . . ANDA NO. THERAPEUTICE USE TO PREVENT REJECTION OF KID NEY TRANSPLANTS. TACROLIMUS OINTMENT . GM NDC CODE FDA PRODUCT CODE NO. T C |
| 2025-10-14 |
MAEU259327243 |
GLENMARK PHARMACEUTICALS INC |
2065.24 kg |
846249.0
|
PART OF FCL PACKAGES CARTONS PHARMACEU TICALS AS UNDER CETIRIZINE HCL TAB MG NDC CODE FDA PRODUCT CODE. X C A HTS NO. . . ANDA NO. THERA PEUTICE USE. ANTIHISTAMINE CETIRIZINE HCL TA B MG NDC CODE FDA PRODUCT CO DE. X C A HTS NO. . . ANDA NO. THERAPEUTICE |
| 2025-10-14 |
MAEU258745455 |
GLENMARK PHARMACEUTICALS INC |
7821.42 kg |
846249.0
|
PART OF FCL PACKAGES CARTONS PHARMAC EUTICALS AS UNDER CLINDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . . ANDA NO. THERAPEUTICE USE TREATMENT OF NUMEROUS INFECTIONS INCLUDING BUT NOT LIMITED TO SEPTICEMIAINTRA ABDOMINAL INFECTIONS |
| 2025-10-07 |
MAEU258992901 |
GLENMARK PHARMACEUTICALS INC |
3213.76 kg |
551342.0
|
PART OF FCL PACKAGES CARTONS PHARMACE UTICALS AS UNDER HAILEY FE . TAB . MG MCG MG NDC CODE FDA PRODUCT CO DE NO. J D A H. T. S NO. . . . ANDA NO. THERAPEUTICE USE HORMONE MEDIC ATION IS USED TO PREVENT PREGNANCY COMMERCIA L CUSTOM INVOICE NO. F DT. . . S |
| 2025-09-23 |
EXDO62C0269964 |
AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH PACKAGING |
11783.0 kg |
520300.0
|
ONDANSETRON ODT MG UD (BP) HTS: |
| 2025-09-23 |
MAEU258288705 |
GLENMARK PHARMACEUTICALS INC |
7414.55 kg |
846249.0
|
PACKAGES CARTONS PHARMACEUTICALS AS U NDER CLINDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . . ANDA NO. THERAPE UTICE USE TREATMENT OF NUMEROUS INFECTIONS INCLUDING BUT NOT LIMITED TO SEPTICEMIAINTRAABDOMINAL INFECTIONS LOWER RESPIR |
| 2025-09-17 |
YASVBOM0074593 |
HIKMA PHARMACEUTICALS USA INC |
2221.0 kg |
300510.0
|
PHARMACEUTICAL COMMODITY |
| 2025-09-14 |
YASVBOM0074582 |
GLENMARK PHARMACEUTICALS INC |
10083.0 kg |
300510.0
|
PHARMACEUTICAL COMMODITY |
| 2025-09-14 |
YASVBOM0074584 |
GLENMARK PHARMACEUTICALS INC |
6977.0 kg |
300510.0
|
PHARMACEUTICAL COMMODITY |
| 2025-09-14 |
YASVBOM0074600 |
GLENMARK THERAPEUTICS INC USA |
2443.0 kg |
300510.0
|
PHARMACEUTICAL COMMODITY |
| 2025-09-09 |
MAEU257878981 |
GLENMARK PHARMACEUTICALS INC |
1408.43 kg |
846249.0
|
PART OF FCL PACKAGES CARTONS PHARMACEU TICALS AS UNDER ROSUVASTATIN TAB MG N DC CODE FDA PRODUCT CODE NO. J C A H. T. S NO. . . . ANDA NO. THERAPEUTICE USE TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS AND TO PREVENT CARDIO VASCULAR DISEASE ROSUVASTATI |
| 2025-09-09 |
MAEU257862138 |
GLENMARK PHARMACEUTICALS INC |
6962.31 kg |
551342.0
|
PART OF FCL PACKAGES CARTONS PHARMAC EUTICALS AS UNDER OMEPRAZOLE DR CAP MG NDC CODE FDA PRODUCT CODE NO. K CF HTS NO. . . ANDA NO. THERAP EUTICE USE TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE ONDANSETRON ODT MG UD ND C CODE FDA PRODUCT CODE. T C |
| 2025-09-09 |
MAEU257771897 |
GLENMARK PHARMACEUTICALS INC |
9164.99 kg |
551342.0
|
PART OF FCL PACKAGES CARTONS PHARMAC EUTICALS AS UNDER ROPINIROLE TAB . MG NDC CODE FDA PRODUCT CODE NO. J C A H. T. S NO. . . . ANDA NO. THERAPEUTICE USETREATMENT OF PARKINSONISM NAPROXEN TAB MG NDC CODE F DA PRODUCT CODE NO. G C A H. T. S NO. . . . ANDA |
| 2025-09-09 |
MAEU257562047 |
GLENMARK PHARMACEUTICALS INC |
8461.91 kg |
290719.0
|
PACKAGES CARTONS PHARMACEUTICALS AS U NDER CLINDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . . ANDA NO. THERAPEU TICE USE TREATMENT OF NUMEROUS INFECTIONS INCLUDING BUT NOT LIMITED TO SEPTICEMIAINTRAABDOMINAL INFECTIONS LOWER RESPIR |
| 2025-09-07 |
EXDO62C0268808 |
NORTHSTAR DISTRIBUTION CENTER 8912 |
5767.0 kg |
281122.0
|
METRONIDAZOLE VAG GEL % GM (NS) HTS: |
| 2025-09-02 |
MAEU257567853 |
GLENMARK PHARMACEUTICALS INC |
355.62 kg |
551342.0
|
PART OF FCL PACKAGES CARTONS PHARMACEUT ICALS AS UNDER ROSUVASTATIN TAB MG ND C CODE J C A . . . TO TREAT HIGH CHOLESTEROL AND RELATED CO NDITIONS AND TO PREVENT CARDIOVASCULAR DISEASE COMMERCIAL CUSTOM INVOICE NO. F DT. . . SBILL NO DT JUL GROSS WT. . KG |
| 2025-09-02 |
MAEU257330846 |
GLENMARK PHARMACEUTICALS INC |
9323.75 kg |
551342.0
|
PACKAGES CARTONS PHARMACEUTICALS AS U NDER TOPIRAMATE ER CAP (Q) MG NDC CODE . . . M C B CLINDAMYCIN HCL CAP MG NDC CODE FDA PRODUCT CODE NO. J C E H. T. S NO. . . ANDA NO. THERAPEUTICE USE TREATMENT OF NUMEROUS INFECTIONS INCLUDIN G BUT NOT LIMITED TO SE |
| 2025-08-26 |
MAEU257123391 |
GLENMARK PHARMACEUTICALS INC |
3666.45 kg |
721640.0
|
PART OF FCL PACKAGES CARTONS PHARMAC EUTICALS AS UNDER ROSUVASTATIN TAB MG N DC CODE FDA PRODUCT CODE NO. J C A H. T. S NO. . . . ANDA NO. THERAPEUTICE USE TO TREAT HIGH CHOLESTERO L AND RELATED CONDITIONS AND TO PREVENT CARDIOVASCULAR DISEASE ACYCLOVIR O |
| 2025-08-26 |
MAEU256986718 |
GLENMARK PHARMACEUTICALS INC |
7537.92 kg |
847439.0
|
PART OF FCL PACKAGES CARTONS PHARMAC EUTICALS AS UNDER METFORMIN HCL ER TAB (Z) MG NDC CODE FDA PRODUCT CODE NO. P C A H. T. S NO. . . . AN DA NO. THERAPEUTICE USE THE MANAGEMENT OF TYPE DIABETES BISOPROLOLHCTZ TAB . MG NDC CODE FDA PRODUCT CODE NO O D A |
| 2025-08-26 |
MAEU257205254 |
GLENMARK PHARMACEUTICALS INC |
961.18 kg |
551342.0
|
PART OF FCL PACKAGES CARTONS PHARMACEU TICALS AS UNDER NITROGLYCERIN SUBLING TAB . MG X NDC CODE FDA PRODUCT CODE NO. S C A H. T. S NO. . . AND A NO. THERAPEUTIC USE MEDICATION USED F OR HEART FAILUREHIGH BLOOD PRESSUREAND TO TREAT AND PREVENT CHEST PAIN |
| 2025-08-26 |
MAEU257191573 |
GLENMARK PHARMACEUTICALS INC |
3757.62 kg |
551342.0
|
PART OF FCL PACKAGES CARTONS PHARMACE UTICALS AS UNDER OMEPRAZOLE DR CAP MG NDC CODE FDA PRODUCT CODE NO. KC F HTS NO. . . ANDA NO. THERAPE UTICE USE TREATMENT OF TREAT GASTROESOPHAGEALREFLUX DISEASE ATOVAQUONEPROG TAB MG UD NDC CODE FDA PRODUCT CODE NO. |
| 2025-08-23 |
EXDO62C0268282 |
AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH PACKAGING |
2268.0 kg |
520300.0
|
ONDANSETRON ODT MG UD (BP) HTS: |
| 2025-08-19 |
MAEU257140522 |
GLENMARK PHARMACEUTICALS INC |
1214.29 kg |
620300
|
PART OF FCL 5 PACKAGES 98 CARTONS PHARMACEUT ICALS AS UNDER AZELAIC ACID GEL 15 50GM NDC CODE68462062652 FDA PRODUCT CODE NO. 62 S C J03 H. T. S NO. 3004.49.00.50 ANDA NO. 204637 INDICATED FOR TOPICAL TREATMENT OF THE INFLA MMATORY PAPULES AND PUSTULES OF |
| 2025-08-19 |
MAEU257141126 |
GLENMARK PHARMACEUTICALS INC |
1212.47 kg |
620300
|
PART OF FCL 5 PACKAGES 98 CARTONS PHARMACEUT ICALS AS UNDER AZELAIC ACID GEL 15 50GM NDC CODE68462062652 FDA PRODUCT CODE NO. 62 S C J03 H. T. S NO. 3004.49.00.50 ANDA NO. 204637 INDICATED FOR TOPICAL TREATMENT OF THE INFLA MMATORY PAPULES AND PUSTULES OF |
| 2025-08-19 |
MAEU255885062 |
GLENMARK PHARMACEUTICALS INC |
10361.58 kg |
300490
|
37 PACKAGES 2357 CARTONS PHARMACEUTICALS AS UNDER GABAPENTIN TAB 600MG 500 NDC CODE684620 12605 FDA PRODUCT CODENO 61 N C A 69 HTS NO. 3004.90.9236 ANDA NO.77662 THERAPEUTICE USEANTICONVULSANT CLINDAMYCIN HCL CAP 150MG 100 N DC CODE68462014301 FDA PRODUCT |
| 2025-08-19 |
MAEU256582931 |
GLENMARK PHARMACEUTICALS INC |
644.57 kg |
617200
|
PART OF FCL 3 PACKAGES 262 CARTONS PHARMACEU TICALS AS UNDER SOLIFENACIN SUCCINATE TAB 10 MG 90 NDC CODE68462038790 FDA PRODUCT CODE NO. 61 KCA 72 H. T. S NO. 3004 49 00 70 ANDA NO. 209239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLADDER WITH SYMPTOMS OF |
| 2025-08-18 |
EXDO62C0267999 |
NORTHSTAR DISTRIBUTION CENTER 8912 |
9979.0 kg |
300490
|
ROSUVASTATIN TAB 40MG 30 (NS) HTS: 30049099 |
| 2025-08-16 |
EXDO62C0269648 |
AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH PACKAGING |
9866.0 kg |
300490
|
ZONISAMIDE CAP 100MG 100 (BP) HTS: 30049081 |
| 2025-08-11 |
MAEU256528138 |
GLENMARK PHARMACEUTICALS INC |
1210.66 kg |
662800
|
PART OF FCL 6 PACKAGES 162 CARTONS PHARMACEU TICALS AS UNDER NITROGLYCERIN SUBLING TAB 0. 3MG 100 NDC CODE68462063801 FDA PRODUCT CODE NO. 66 S C A 28 H. T. S NO. 3004.90.9020 ANDANO.206391 THERAPEUTIC USE MEDICATION USED FO R HEART FAILUREHIGH BLOOD PRES |
| 2025-08-11 |
MAEU255885349 |
GLENMARK PHARMACEUTICALS INC |
7140.57 kg |
300490
|
PART OF FCL 35 PACKAGES 3146 CARTONS PHARMAC EUTICALS AS UNDER TACROLIMUS CAP 1MG 100 NDC CODE68462068601 HTS NO 3004.90.92.15 FDA COD E 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE TO PREVENT REJECTION OF A KIDNEYHEART OR LI VER TRANSPLANT TACROLIMUS OINTM |
| 2025-08-11 |
EXDO62C0267995 |
NORTHSTAR DISTRIBUTION CENTER 8912 |
8107.0 kg |
300490
|
ROSUVASTATIN TAB 10MG 90 (NS) HTS: 30049099 |
| 2025-08-10 |
EXDO62C0268241 |
AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH PACKAGING |
6782.0 kg |
300490
|
ONDANSETRON ODT 4MG 1UD (BP) HTS: 30049099 |
| 2025-08-10 |
EXDO62C0267946 |
AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH PACKAGING |
7961.0 kg |
300490
|
ONDANSETRON ODT 4MG 1UD (BP) HTS: 30049035 |
| 2025-08-09 |
YASVBOM0073710 |
GLENMARK PHARMACEUTICALS INC |
8934.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-08-08 |
MAEU255452533 |
GLENMARK PHARMACEUTICALS PERU SA |
2809.14 kg |
300490
|
TOTAL PALLETS 18 (EIGHTEEN) ONLY (306 CARTONSONLY) PHARMACEUTICALS TACROZ FORTE OINTMEN T 10 GM BUDESMA 200MCG200MD COMBIWAVE SF 125 MCG120 MD CANDITRAL CAPSULES 4X4S HSN CODE N O 30049099 30049029 COMMERCIAL INV. NO. F226 00000601 DT. 19.06.2025 SAP INV. |
| 2025-08-03 |
EXDO62C0267320 |
AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH PACKAGING |
2720.0 kg |
300490
|
FLUCONAZOLE TAB 150MG 12UD (BP) HTS: 30049029 |
| 2025-08-03 |
EXDO62C0267319 |
AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH PACKAGING |
7812.0 kg |
300490
|
FLUCONAZOLE TAB 150MG 12UD (BP) HTS: 30049081 |
| 2025-08-01 |
YASVBOM0073572 |
GLENMARK PHARMACEUTICALS INC |
6365.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-08-01 |
YASVBOM0073600 |
GLENMARK PHARMACEUTICALS INC |
1930.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-07-27 |
YASVBOM0073412 |
GLENMARK PHARMACEUTICALS INC |
8089.0 kg |
300510
|
PHARMACEUTICAL COMMODITY |
| 2025-07-17 |
EXDO62C0266676 |
NORTHSTAR DISTRIBUTION CENTER 8912 |
3996.0 kg |
300490
|
ROSUVASTATIN TAB 10MG 90 NS HTS: 30049099 |